Wells Fargo Upgrades Johnson & Johnson (JNJ) to Outperform; Pharma Pipeline Moves To Forefront As Consumer Risk Dissipates

Go back to Wells Fargo Upgrades Johnson & Johnson (JNJ) to Outperform; Pharma Pipeline Moves To Forefront As Consumer Risk Dissipates